IFNGR1 and neoplasm: Given that PTPN2 is a negative feedback regulator of IFNγR/JAK/STAT signaling, we hypothesized that depletion of anti-Ptpn2 sgRNA expressing cells in vitro may result from hypersensitization of tumor cells to IFNγR signaling.